Moderate to high use of opioid analgesics are associated with an increased risk of Clostridium difficile infection

American Journal of the Medical Sciences

Volumn 343, Issue 4, 2012, Pages 277-280

  Mora, Andrea L ^a,b   Salazar, Miguel ^b   Pablo Caeiro, Juan ^b,c   Frost, Craig P ^d   Yadav, Yashoo ^b   Dupont, Herbert L ^b,c,d,e   Garey, Kevin W ^b,d,e  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF HOUSTON   (United States)

^e UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Clostridium difficile; Opioid analgesics; Risk factor analysis

Indexed keywords

CEFEPIME; CEFTRIAXONE; DEXTROPROPOXYPHENE PLUS PARACETAMOL; FENTANYL; HYDROCODONE BITARTRATE PLUS PARACETAMOL; HYDROMORPHONE; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MORPHINE; NITAZOXANIDE; OPIATE; OXYCODONE; OXYCODONE PLUS PARACETAMOL; PETHIDINE; PIPERACILLIN PLUS TAZOBACTAM; RIFAXIMIN; VANCOMYCIN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; FEMALE; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK FACTOR;

EID: 84859102177     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31822f42eb     Document Type: Article

References (22)

1. Elliott B, Chang BJ, Golledge CL, et al. Clostridium difficile-associated diarrhoea. Intern Med J 2007;37:561-8. (Pubitemid 47084173)
2. Ricciardi R, Rothenberger DA, Madoff RD, et al. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007;142:624-31; discussion 31.
3. Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 2005;5:549-57. (Pubitemid 41196754)
4. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. New Eng J Med 2005;353: 2433-41. (Pubitemid 41770164)
5. De Luca A, Coupar IM. Insights into opioid action in the intestinal tract. Pharmacol Ther 1996;69:103-15. (Pubitemid 26111425)
6. Schiller LR, Santa Ana CA, Morawski SG, et al. Mechanism of the antidiarrheal effect of loperamide. Gastroenterology 1984;86:1475-80. (Pubitemid 14147940)
7. Panchal SJ, Muller-Schwefe P, Wurzelmann JI. Opioid-induced bowel dysfunction: prevalence, pathophysiology and burden. Int J Clin Pract 2007;61:1181-7. (Pubitemid 46934629)
8. Patanwala AE, Duby J, Waters D, et al. Opioid conversions in acute care. Ann Pharmacother 2007;41:255-66.
9. Pappagallo M. Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 2001;182:11S-8S. (Pubitemid 34072942)
10. Bartlett JG. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 2006;145:758-64. (Pubitemid 351650356)
11. Gerding DN, Johnson S, Peterson LR, et al. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995; 16:459-77.
12. Dubberke ER, Reske KA, Olsen MA, et al. Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease. Arch Intern Med 2007;167:1092-7. (Pubitemid 46835798)
13. Muto CA, Pokrywka M, Shutt K, et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005; 26:273-80. (Pubitemid 40445086)
14. Walker KJ, Gilliland SS, Vance-Bryan K, et al. Clostridium difficile colonization in residents of long-term care facilities: prevalence and risk factors. J Am Geriatr Soc 1993;41:940-6. (Pubitemid 23262320)
15. Brown JW. Toxic megacolon associated with loperamide therapy. JAMA 1979;241:501-2. (Pubitemid 9228148)
16. Caumes E, Menegaux F, Hoang C, et al. From travelers' diarrhea to abdominal surgery: report of three cases. J Travel Med 2004;11:117-9. (Pubitemid 38523687)
17. Loffeld RJ, Soeters PB. [Small intestinal perforation as complication of loperamide treatment of Salmonella typhimurium infection]. Ned Tijdschr Geneeskd 1990;134:1611-3.
18. McGregor A, Brown M, Thway K, et al. Fulminant amoebic colitis following loperamide use. J Travel Med 2007;14:61-2. (Pubitemid 46114988)
19. Olm M, Gonzalez FJ, Garcia-Valdecasas JC, et al. Necrotising colitis with perforation in diarrhoic patients treated with loperamide. Eur J Clin Pharmacol 1991;40:415-6.
20. Schneider A, Runzi M, Peitgen K, et al. Campylobacter jejuni-induced severe colitis-a rare cause of toxic megacolon. Z Gastroenterol 2000;38:307-9. (Pubitemid 30241362)
21. von Muhlendahl KE, Bunjes R, Krienke EG. Loperamide-induced ileus. Lancet 1980;1:209. (Pubitemid 10208016)
22. Walley T, Milson D. Loperamide related toxic megacolon in Clostridium difficile colitis. Postgrad Med J 1990;66:582. (Pubitemid 20208057)